Valneva

Description: 

A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines. IXIARO is Valneva’s Japanese encephalitis vaccine that is licensed in more than 35 countries including the U.S.. Valneva is committed to protecting travelers worldwide.

Booth Number: 
416
Exhibitor Type: 
Biotechnology Pharmaceuticals